Westminster Hall is an alternative Chamber for MPs to hold debates, named after the adjoining Westminster Hall.
Each debate is chaired by an MP from the Panel of Chairs, rather than the Speaker or Deputy Speaker. A Government Minister will give the final speech, and no votes may be called on the debate topic.
This information is provided by Parallel Parliament and does not comprise part of the offical record
The Parliamentary Under-Secretary of State for Health and Social Care (Maggie Throup)
I thank my hon. Friend the Member for Penistone and Stocksbridge (Miriam Cates) for securing this important and timely debate on the vaccination of 12 to 15-year-olds against covid-19. She quite rightly highlighted the importance of vaccine roll-outs and the programmes that we have had for many decades, and I thank her for that.
Before I respond to the various questions and points raised by hon. Members, I pay tribute to my predecessor, my right hon. Friend the Member for Stratford-on-Avon (Nadhim Zahawi), for his efforts in successfully delivering the vaccine programme, with more than 93 million doses administered in the UK and more than four fifths of adults receiving the protection of two jabs. I aim to build on that very solid foundation in my new role.
I also put on record that I am very grateful to everyone who has played a crucial role in the success of the vaccine roll-out, from our brilliant scientists, clinical trial participants, the armed forces, NHS England, frontline healthcare workers, vaccine volunteers and local and central Government. Our jabs have already prevented more than 112,000 deaths, 230,000 hospitalisations and more than 24 million infections. They have built a vast wall of defence for the British people.
Earlier this year, our medicines regulator, the MHRA, approved the Pfizer and Moderna vaccines for 12 to 17-year-olds. The MHRA authorisation decision confirmed that vaccines are safe and effective for this age group. On this decision, the Joint Committee on Vaccination and Immunisation recommended vaccination for 12 to 15-year-olds with serious underlying health conditions. In August, the committee advised an initial dose of the vaccine for all healthy remaining 16 and 17-year-olds. The JCVI then looked at whether we should extend our offer of vaccination to all 12 to 15-year-olds. It concluded that there are health benefits to vaccinating this cohort, although they are finely balanced.
However, the JCVI’s remit does not include the wider impacts of vaccinations, such as the benefits for children in education or the mental health benefits that come from people knowing that they are protected from this deadly virus. The JCVI therefore advised that the Government might wish to seek further views on those wider impacts from the UK’s chief medical officers across all four nations. The Secretary of State and the Health Ministers from the devolved nations accepted that advice. Our CMOs consulted clinical experts and public health professionals from across the United Kingdom, such as those from the Royal College of Paediatrics and Child Health. I trust that that reassures my hon. Friend the Member for Northampton South (Andrew Lewer), who raised concerns about professional advice.
We received advice from the four chief medical officers, and it was made publicly available and deposited in the Library for Members to read in full. The unanimous recommendation of the UK’s chief medical officers is to offer all remaining 12 to 15-year-olds a first dose of the Pfizer vaccine, with further JCVI guidance needed before any decision on a second dose. The CMOs have been clear that they make this recommendation based on the benefits to children alone, not on the benefits to adults or wider society.
I can confirm that the Government accepted this recommendation. We are now moving forward with the same sense of urgency that we have had at every point in our vaccination programme. I am delighted that a 14-year-old in Essex yesterday became one of the first children in the country to receive a covid-19 vaccination in school.
Chris Green
Will my hon. Friend set out exactly why it is recommended for adults to have two doses and perhaps later a booster dose of the vaccine, but for children it is a single dose?
Maggie Throup
I thank my hon. Friend for his intervention, and I reassure him that the evidence is continually being observed and recorded. Further advice will be taken on whether a second dose is needed for the younger age range. Evidence is being gathered all the time.
I appreciate that there are questions about how the process of consent will work in circumstances where parents and children disagree. I reassure my hon. Friend the Member for St Ives (Derek Thomas) that, as with all vaccinations for children, parental consent will be sought. The consent process is being handled by each school in its usual way and provides sufficiently for parents to give their consent. Children aged 12 to 15 will also be provided with information, usually in the form of a leaflet for their own use and to share and discuss with parents prior to the date on which the immunisation is scheduled.
Parental, guardian or carer consent will be sought by the school age immunisation service prior to vaccination, in line with other school vaccination programmes. That service will carry out the vaccinations, and I trust that that reassures my hon. Friend the Member for Northampton South. The school age vaccination service has vast experience of dealing with a number of other vaccine roll-outs in secondary schools, such as the human papillomavirus vaccine and the three-in-one teenage booster that protects against tetanus, diphtheria and polio. The clinicians who work on these roll-outs are very well equipped and very well versed in dealing with vaccines in schools.
In their advice, the four CMOs have said it is essential that children and young people aged 12 to 15, and their parents, are supported in whatever decisions they take, and that they are not stigmatised for accepting or not accepting the vaccination offer. Individual choice should be respected. It is the opportunity to be vaccinated that is on offer, in a fair and equitable manner.
To those who remain undecided, I say this. The MHRA is the best medical regulator in the world. It has rigorously reviewed the safety of our vaccines, and it only authorises those that it concludes are safe. Vaccines for children and young people are no exception. We continue to have a comprehensive safety surveillance strategy in place across all age groups to monitor the safety of all covid-19 vaccines that are approved for use in the UK.
I will now address some of the interventions and questions from hon. Members. My hon. Friend the Member for Penistone and Stocksbridge asked a number of questions. I reiterate that the CMOs sought advice from experts in the field; it was not just the information they had themselves. It is only right that, based on that advice, 12 to 15-year-olds are able to take up the offer of the vaccine in a fair and equitable manner.
My hon. Friend asked about disruption to education from the programme. NHS England already has plans in place for the mop-up programme, which is not likely to be on school sites, to minimise disruption to education and the rest of the immunisation programme.
Miriam Cates
I very much appreciate the point and the reassurance the Minister is giving, but even the CMOs acknowledge that the vaccine programme in and of itself is not going to end disruption to schools. Whether people choose to have this vaccine or not—which absolutely should be a free decision, as the Minister says—what is more important is the policy making around having consistent rules in schools, as the hon. Member for Strangford (Jim Shannon) said, but also ending mass asymptomatic testing, which is picking up cases that it does not need to pick up and is itself causing disruption. How will the disruption to schools end, even if vaccination does go ahead and cover a wide population?
Maggie Throup
I thank my hon. Friend for that intervention. It is important that we do whatever we can—use whatever we have in our toolbox—to make sure that children are able to continue with their education, and vaccination is one part of that. I know my hon. Friend is passionate, as am I, about making sure that children get a full education, and that the pandemic does not affect their futures. My hon. Friend raised several other questions and, if she will allow me, I will write to her in response to any I do not answer in my speech.
My hon. Friend the Member for Lincoln (Karl MᶜCartney) raised questions about guidance for schools on the vaccination programme. How the programme will work has been set out very clearly, including in the formation of the consent process, most recently updated on 17 September 2021. I would like to reassure my hon. Friend, who highlighted the three words “do no harm”, that robust monitoring arrangements are in place for the vaccination of 12 to 15-year-olds, and that further data will be available shortly.
I join the hon. Member for Leicester West (Liz Kendall) in absolutely condemning the threats and intimidation of headteachers, school staff and anybody who enters school premises. That is a big issue, and my advice is that headteachers who have received such intimidation should rapidly contact the school age immunisation service, which is well versed in addressing it. They should not be afraid to speak to the police and the local authority too. I assure her that that issue is extremely high on my priority list, which, as she can imagine, is getting longer.
It is important that we remember that our teenagers have shown great public spirit at every point during the pandemic, and I thank them for that. They have stuck to the rules so that lives can be saved and people kept safe, and they have been some of the most enthusiastic proponents of vaccines.
Chris Green
Certain drug companies are now looking to get approval for vaccinations for five-year-olds. Does the Minister rule that in or out in the United Kingdom?
Maggie Throup
My focus at the moment is on ensuring the effective roll-out of the programme for 12 to 15-year-olds. We must ensure that the booster programme is rolled out effectively, and encourage the last few people who have not yet had the vaccine—I think it is about 5 million—to take up that offer.
Karl MᶜCartney
I am conscious there are a few minutes left in this debate, so I want to refer quickly to three more issues. First, the Minister may have noticed that the first speech in support of the Government’s position came from an Opposition Member, who claimed to be speaking on behalf of all Opposition MPs, although there is only one here.
Secondly, a point was made about the seat of the hon. Member for Leicester West (Liz Kendall) and the number of young people who have, I believe, covid, although she did not give the actual number. However, if school children were not tested over the summer, surely they are now being tested in school and the incidence of those with covid will be rising. Therefore, I am being very gracious to both Front Benchers—
Karl MᶜCartney
It is, but I am coming to the end of my comments, Dame Angela. I am conscious of that. When I was growing up, there was a very famous pop song called “Don’t Believe the Hype”. Surely that is something we should all be taking notice of.
Maggie Throup
I will take my hon. Friend’s comments on board. More than half of 16 and 17-year-olds across the United Kingdom have had the jab, despite most having become eligible only last month, which shows young people’s enthusiasm to come forward and play their part.
At every point in our vaccination programme, we have been guided by the best clinical advice. The advice that we received from the four chief medical officers last week sets out their view that all 12 to 15-year-olds will benefit from vaccination against covid-19. We will follow that advice and continue that vital path to ensure we keep more and more people in this country safe.